We have found that erythroid burst promoting activity (BPA) is expressed by lymphocyte plasma membranes. We now propose to utilize a biochemically defined culture system to: 1. Purify membrane-associated BPA. We will utilize a variety of biochemical methods, including immunoaffinity, lectin affinity and gel filtration high-performance liquid chromatography (HPLC) and reverse-phase HPLC, to purify BPA from extracts of lymphocyte plasma membranes and shed vesicles. Purified fractions will be characterized by isoelectric focusing and sucrose gradient fractionation. Ultimately, purified BPA will be subjected to amino acid analysis. 2. Determine relatedness of soluble and vesicular BPA. We will employ antisera and monoclonal antibodies that react with BPA to detect whether purified BPA from membranes and in solution are antigenically related. Studies will be performed to determine if both physical forms of BPA are released by similar mechanisms from similar cell types, and if they act on similar marrow subpopulations. Target cells for each growth factor will be characterized histochemically and morphologically. 3. Define kinetics of vesicle-associated BPA release. Cumulative amounts and rates of vesiculation and BPA release by BPA-producing cell populations will be determined. Our findings will be correlated with studies aimed at measuring the biosynthesis of selected membrane components in culture. 4. Examine modes of BPA action. We will determine whether BPA shedding is a constitutive process or part of an immune reaction. Studies will be performed to examine whether vesiculation involves cytoskeletal components and whether membrane lipid and phospholipid composition is important to the shedding process. We will determine whether vesicles associate preferentially with marrow cells and, if so, what the nature of this association might be using electronmicroscopic methods. Ultimately, we will locate and purify BPA receptors with the projected long-range goal to examine intracellular mechanisms for receptor activation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK031060-05
Application #
3229830
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1983-04-01
Project End
1989-04-30
Budget Start
1987-05-01
Budget End
1988-04-30
Support Year
5
Fiscal Year
1987
Total Cost
Indirect Cost
Name
St. Elizabeth's Medical Center of Boston
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02135
Sanders, M R; Lu, H; Walker, F et al. (1998) The Raf-1 protein mediates insulin-like growth factor-induced proliferation of erythroid progenitor cells. Stem Cells 16:200-7
Tuck, D P; Cerretti, D P; Hand, A et al. (1994) Human macrophage colony-stimulating factor is expressed at and shed from the cell surface. Blood 84:2182-8
Sanders, M; Sorba, S; Dainiak, N (1993) Insulin-like growth factors stimulate erythropoiesis in serum-substituted umbilical cord blood cultures. Exp Hematol 21:25-30
Guha, A; Dainiak, N; Freedman, M et al. (1993) Regulatory effect of interferon-gamma and phorbol esters on the surface expression and biosynthesis of MHC class I antigens by human leukemia cells. Cell Immunol 151:404-13
Guha, A; Tuck, D; Sorba, S et al. (1993) Expression of membrane-bound burst-promoting activity is mediated by allogeneic effector cells. Exp Hematol 21:1335-41
Balter, M S; Daniak, N; Chapman, K R et al. (1992) Erythropoietin response to acute hypoxemia in patients with chronic pulmonary disease. Chest 102:482-5
Guha, A; Dainiak, N; Cone, R E (1991) Inhibition of major histocompatibility complex class I antigen shedding up-regulates the surface expression of class I antigens on the lymphocyte cell surface. Ann N Y Acad Sci 628:354-61
Dainiak, N; Sorba, S (1991) Intracellular regulation of the production and release of human erythroid-directed lymphokines. J Clin Invest 87:213-20
Dainiak, N (1991) In utero transplantation of hematopoietic stem cells. Blood Cells 17:376-8
Umlas, J; Kaufman, M; MacQueston, C et al. (1991) A cryoglobulin with cold agglutinin and erythroid stem cell suppressant properties. Transfusion 31:361-4

Showing the most recent 10 out of 19 publications